ATRIPLA, created in 2005 (United States), from 32 sister brands and 17477 competing brands. ATRIPLA is a brand of Gilead Sciences, listed on the stock exchange of New York. ATRIPLA belongs to the Drug Manufacturers business sector.

ATRIPLA is a brand of Gilead Sciences (GILD) Share price

International deposit : 2005 Business sector Drug Manufacturers

Share price and profitability of the share Gilead Sciences (ATRIPLA)

Buy Gilead Sciences share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 67.08

Portfolio valuation
Gilead Sciences (ATRIPLA) over 5 years* USD 69.43

Stock market history Gilead Sciences (ATRIPLA)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Gilead Sciences

EpiTherapeutics
EpiTherapeutics
Nimbus Apollo
Nimbus Apollo
Cell Design Labs
Cell Design Labs
Forty Seven
Forty Seven
GILEAD SCIENCES
GILEAD SCIENCES
Kite Pharma
Kite Pharma
See more brands of Gilead Sciences

Rival brands
ATRIPLA

POINT BIOPHARMA
POINT BIOPHARMA
Icosavax
Icosavax
OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
LACTAID
LACTAID
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS